Medifast, Inc. (MED)

Medifast Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	224	732	1,260	2,433	2,311	1,273
Market Cap Growth	-62.86%	-41.91%	-48.19%	5.27%	81.56%	-14.91%
Enterprise Value	88	604	1,199	2,356	2,148	1,194
PE Ratio	3.30	7.37	8.78	14.83	22.47	16.34
PS Ratio	0.25	0.68	0.79	1.59	2.47	1.78
PB Ratio	1.06	3.63	8.13	12.02	14.70	12.14
P/FCF Ratio	2.65	5.19	7.09	40.32	16.59	17.15
P/OCF Ratio	2.46	4.96	6.48	25.73	15.92	15.11
EV/Sales Ratio	0.10	0.56	0.75	1.54	2.30	1.67
EV/EBITDA Ratio	0.87	4.20	5.94	10.32	15.17	12.14
EV/EBIT Ratio	1.06	4.78	6.49	10.89	16.02	13.11
EV/FCF Ratio	1.04	4.28	6.74	39.04	15.42	16.09
Debt / Equity Ratio	0.10	0.11	0.17	0.16	0.07	0.13
Debt / EBITDA Ratio	0.20	0.15	0.13	0.14	0.08	0.14
Debt / FCF Ratio	0.24	0.16	0.15	0.54	0.08	0.18
Quick Ratio	2.03	1.63	0.62	0.65	1.57	1.19
Current Ratio	2.85	2.43	1.58	1.81	2.10	1.94
Asset Turnover	2.87	3.38	4.55	4.18	3.85	3.50
Interest Coverage	-	-	263.57	936.62	-	-
Return on Equity (ROE)	34.30%	53.00%	88.20%	85.40%	78.40%	67.20%
Return on Assets (ROA)	21.70%	31.30%	40.90%	44.90%	42.40%	38.20%
Return on Capital (ROIC)	27.18%	43.66%	79.60%	69.83%	61.03%	64.85%
Earnings Yield	30.25%	13.58%	11.39%	6.74%	4.45%	6.12%
FCF Yield	37.80%	19.28%	14.11%	2.48%	6.03%	5.83%
Dividend Yield	8.06%	7.40%	5.70%	2.70%	2.30%	3.10%
Payout Ratio	26.61%	54.20%	51.20%	40.50%	51.70%	51.10%
Buyback Yield / Dilution	-0.54%	3.15%	4.55%	0.31%	2.20%	-0.31%
Total Shareholder Return	7.52%	10.55%	10.25%	3.01%	4.50%	2.79%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).